vimarsana.com

Latest Breaking News On - Sound bioventures - Page 1 : vimarsana.com

Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158

/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces.

Cambridge
Cambridgeshire
United-kingdom
Boston
Massachusetts
United-states
Artax-biopharma
Jamesg-krueger
Rob-armstrong
Company-phase
Linkedin
Advent-life-sciences

Breye Therapeutics Commences Oral Dosing of Danegaptide in Patients with Diabetic Retinopathy

Breye Therapeutics Commences Oral Dosing of Danegaptide in Patients with Diabetic Retinopathy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Denmark
Copenhagen
Køavn
Wills-eye-hospital
Pennsylvania
United-states
Philadelphia
Thomas-jefferson-university
Danish
Carl-regillo
Ulrik-mouritzen
Stefan-klotter

Breye Therapeutics ApS developing oral ophthalmology drugs

Sound Bioventures appoints Fredrik Lehmann as its first

Stockholm, Sweden and Cambridge, MA, USA – 13 October 2023 - Sound Bioventures, a venture capital fund investing in about-to-be clinical or clinical stage.

Cambridge
Cambridgeshire
United-kingdom
Denmark
United-states
Stockholm
Sweden
Swedish
Frazer-hall-mark
Fredrik-lehmann
Stockholm-school-of-economics
Bioventures-fund

Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence

Sound Bioventures appoints Fredrik Lehmann as its first Entrepreneur-in-Residence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Cambridge
Cambridgeshire
United-kingdom
Stockholm
Sweden
Denmark
Swedish
Fredrik-lehmann
Frazer-hall-mark
Head-of-research
Oncopeptides-as-head-of-research
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.